Primary testicular non-Hodgkin lymphoma. a 10-year Tunisian single-institute experience

##plugins.themes.academic_pro.article.sidebar##

Published Aug 21, 2013
Download
pdf
Vol. 91 No. 7 (2013): Issue Jul 2013

##plugins.themes.academic_pro.article.main##

Walid Kerkeni
Mohamed Slim Selmi
Abderrazak Bouzouita
Nadia Znaidi
Mohamed Cherif
Amine Derouiche
Rachida Zermani
Mohamed Riadh Ben Slama
Mohamed Chebil

Abstract

Background: Primary testicular non-Hodgkin lymphoma (NHL) is an uncommon extra nodal presentation, accounting for 1% of all NHL and 1 to 9% of testicular neoplasms. Median age at time of presentation is 60 years old. Anthracycline based chemotherapies are most frequently used.
aim: To analyze baseline characteristics, treatment modalities and survival of six cases of primary testicular non-Hodgkin lymphoma.
methods: We screened 46 testicular neoplasm cases registered from January 1999 to January 2009 and found six primary testicular lymphoma patients. These six cases were analyzed for baseline clinical features, investigations, treatment and outcome variables.
results: Median age was 50 years old and median duration of symptoms was 4 months. All patients had testicular swelling. Four patients had abdominal lymphadenopathy. Most patients had diffuse large B-cell histology. All patients underwent high inguinal orchidectomy and five were treated with anthracycline based chemotherapy. Four patients completed therapy and one of them relapsed two years later.
Conclusion: Primary testicular NHL is an uncommon entity and with current combined modality treatment, the outcome may be as good as nodal NHL.

Keywords:

Extranodal; non hodgkin lymphoma; testi

##plugins.themes.academic_pro.article.details##

References

  1. Gupta D, Sharma A, Raina V, Bakhshi S, Mohanti BK. Primary testicular non-Hodgkin lymphoma: A single institution experience from India. Indian J Cancer 2009; 46:46-9.
  2. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29:252-60.
  3. Connors JM, Klimo P, Voss N, Fairey RN, Jackson S. Testicular lymphoma: Improved outcome with early brief chemotherapy. J Clin Oncol 1988; 6:776-81.
  4. Pingali S, Go RS, Gundrum JD, Wright L, Gay G. Adult testicular lymphoma in the United States (1985-2004): Analysis of 3669 cases from the National Cancer Data Base (NCDB). J Clin Oncol 2008; 26 suppl: abstr 19503.
  5. Gundrum JD, Mathiason MA, Go RS, Moore DB. Adult diffuse large B cell lymphoma of the testis: Analysis of the Surveillance Epidemiology and End Results (SEER) data base from 1980- 2004. J Clin Oncol 2008; 26 suppl: abstr 19524.
  6. Ferry JA, Harris NL, Young RH, Coen J, Zietman A, Scully RE. Malignant lymphoma of the testis, epididymis, and spermatic cord: A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994; 18:376-90.
  7. Bouziani A, M'sakni I, Bougrine F, et al. Le lymphome malin non hodgkinien : une cause rare de tumeur testiculaire. Prog Urol 2004; 14:1221-3.
  8. Vural F, Cagirgan S, Saydam G, Hekimgil M, Soyer NA, Tombuloglu M. Primary testicular lymphoma. J Natl Med Assoc 2007; 99:1277-82.
  9. Zucca E, Conconi A, Mughal TI, et al. Patterns of outcome and prognostic factors in primary large cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study group. J Clin Oncol 2003; 21:20-7.
  10. Darby S, Hancock BW. Localized non-Hodgkin lymphoma of the testis: the Sheffield Lymphoma Group experience. Int J Oncol 2005; 26:1093-9.
  11. Pectasides D, Economopoulos T, Kouvatseas G, et al. Anthracycline based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience. Oncology 2000; 58:286-92.
  12. Sénéchal C, Saint F, Petit T, Petit J. Non-Hodgkin's primitive lymphoma of the testis: Long-term prognosis associated with treatment combining systemic and intrathecal chemotherapy. Prog urol 2009; 19:209-14.
  13. Sasai K, Yamabe H, Tsutsui K, et al. Primary testicular non- Hodgkin's lymphoma: a clinical study and review of the literature. Am J Clin Oncol 1997; 20:59-62.
  14. Hasselblom S, Ridell B, Wedel H, Norrby K, Sender Baum M, Ekman T. Testicular lymphoma- a retrospective, populationbased, clinical and immunohistochemical study. Acta Oncol 2004; 43:758-65.
  15. Gundrum JD, Mathiason MA, Moore DB, Go RS. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of Rituximab. J Clin Oncol 2009; 27:5227-32.
  16. Chelly I, Mekni A, Bellil K, et al. Testicular lymphoma: report of 4 cases. Tunis Med 2007; 85:896-8.
  17. Miedler JD, MacLennan GT. Primary Testicular Lymphoma. J Urol 2007; 178:2645.
  18. Davis JW, Moriarty RP, Schlossberg SM, Schellhammer PF. Testicular lymphoma treated with chemotherapy and radiation without orchidectomy: complete response relapsed at 52 months in the vitreous humor. Urology 2001; 57:555.
  19. Touroutoglou N, Dimopoulos MA, Younes A, et al. Testicular lymphoma: Late relapses and poor outcome despite doxorubicinbased therapy. J Clin Oncol 1995; 13:1361-7.
  20. Moller MB, D'Amore F, Christensen BE. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer 1994; 30:1760-/4.
  21. Lagrange JL, Ramaioli A, Theodore CH, Terrier-Lacombe MJ, Beckendorf V, Biron P. Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centers. Ann Oncol 2001; 12:1313-9.
  22. Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with a higher incidence of extra nodal recurrence. Cancer 2000; 88:154-61.
  23. Seymour JF, Solomon B, Wolf MM, Janusczewicz EH, Wirth A, Prince HM. Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. Clin Lymphoma 2001; 2:109-15.
  24. Niitsu N, Umeda M. Clinical features of testicular non-Hodgkin lymphoma: Focus on treatment strategy. Acta Oncol 1998; 37:677-80.
  25. Visco C, Medeiros LJ, Mesina OM, Rodriguez MA, Hagemeister FB, McLaughlin P. Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin based therapy? Clin Lymphoma 2001; 2:40-6.
  26. Zouhair A, Weber D, Belkacémi Y, Ketterer N, Dietrich PY, Villà S. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2002; 52:652-6.